help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weiss, L. M.
Right arrow Articles by Shibata, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, L. M.
Right arrow Articles by Shibata, D.

American Journal of Pathology, Vol 139, 1259-1265, Copyright © 1991 by American Society for Investigative Pathology


REGULAR ARTICLES

Epstein-Barr virus and Hodgkin's disease. A correlative in situ hybridization and polymerase chain reaction study

LM Weiss, YY Chen, XF Liu and D Shibata
Department of Pathology, City of Hope National Medical Center, Duarte, CA 91010.

The authors studied typical Hodgkin's disease along with the nodular, lymphocyte predominance subtype by both the polymerase chain reaction (PCR) and in situ hybridization for evidence of the Epstein-Barr virus (EBV). By PCR, EBV DNA was detected in 12/23 cases of typical Hodgkin's disease and 2/13 cases of the nodular, lymphocyte predominance subtype. EBV RNA was detected by in situ hybridization studies within Reed- Sternberg cells and variants in 11/23 cases of typical Hodgkin's disease and 0/13 cases of nodular, lymphocyte predominance Hodgkin's disease. Other cells positive for EBV, identified as both B and T cells in double-labeling immunohistochemical/in situ hybridization studies, were found in 20/23 cases of typical Hodgkin's disease, 9/13 cases of nodular, lymphocyte predominance Hodgkin's disease, 4/6 cases of progressive transformation of germinal centers, and 7/10 normal lymphoid tissues. It is concluded that EBV is significantly associated with Reed-Sternberg cells in approximately one-half cases of typical Hodgkin's disease but not in the nodular, lymphocyte predominance subtype. EBV-infected B and T cells are also present in a majority of cases of Hodgkin's disease as well as in reactive conditions.


This article has been cited by other articles:


Home page
JCOHome page
A. Garcia-Herrera, L. Colomo, M. Camos, J. Carreras, O. Balague, A. Martinez, A. Lopez-Guillermo, T. Estrach, and E. Campo
Primary Cutaneous Small/Medium CD4+ T-Cell Lymphomas: A Heterogeneous Group of Tumors With Different Clinicopathologic Features and Outcome
J. Clin. Oncol., July 10, 2008; 26(20): 3364 - 3371.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G Kapatai and P Murray
Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma
J. Clin. Pathol., December 1, 2007; 60(12): 1342 - 1349.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. Wasson, M. N. Zafar, J. Best, and H. K. Reddy
Post-transplantation Lymphoproliferative Disorder in Heart and Kidney Transplant Patients: A Single-Center Experience
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2006; 11(1): 77 - 84.
[Abstract] [PDF]


Home page
JCOHome page
S.-i. Nakatsuka, M. Yao, Y. Hoshida, S. Yamamoto, K. Iuchi, and K. Aozasa
Pyothorax-Associated Lymphoma: A Review of 106 Cases
J. Clin. Oncol., October 15, 2002; 20(20): 4255 - 4260.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. F. Skinnider and T. W. Mak
The role of cytokines in classical Hodgkin lymphoma
Blood, May 29, 2002; 99(12): 4283 - 4297.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
D. A. Arber
Molecular Diagnostic Approach to Non-Hodgkin's Lymphoma
J. Mol. Diagn., November 1, 2000; 2(4): 178 - 190.
[Full Text]


Home page
Mol. Pathol.Home page
K J Flavell and P G Murray
Hodgkin's disease and the Epstein-Barr virus
Mol. Pathol., October 1, 2000; 53(5): 262 - 269.
[Abstract] [Full Text]


Home page
BloodHome page
I. Anagnostopoulos, M.-L. Hansmann, K. Franssila, M. Harris, N. L. Harris, E. S. Jaffe, J. Han, J. M. van Krieken, S. Poppema, T. Marafioti, et al.
European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes
Blood, September 1, 2000; 96(5): 1889 - 1899.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Murono, T. Yoshizaki, H. Sato, H. Takeshita, M. Furukawa, and J. S. Pagano
Aspirin Inhibits Tumor Cell Invasiveness Induced by Epstein-Barr Virus Latent Membrane Protein 1 through Suppression of Matrix Metalloproteinase-9 Expression
Cancer Res., May 1, 2000; 60(9): 2555 - 2561.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
M. E. Kadin
Regulation of CD30 Antigen Expression and Its Potential Significance for Human Disease
Am. J. Pathol., May 1, 2000; 156(5): 1479 - 1484.
[Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
M Engel, M F Essop, P Close, P Hartley, G Pallesen, and C Sinclair-Smith
Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases
J. Clin. Pathol., March 1, 2000; 53(3): 182 - 186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Staratschek-Jox, S. Kotkowski, G. Belge, T. Rudiger, J. Bullerdiek, V. Diehl, and J. Wolf
Detection of Epstein-Barr Virus in Hodgkin-Reed-Sternberg Cells : No Evidence for the Persistence of Integrated Viral Fragments inLatent Membrane Protein-1 (LMP-1)-Negative Classical Hodgkin’s Disease
Am. J. Pathol., January 1, 2000; 156(1): 209 - 216.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. G. Murray, L. J. Billingham, H. T. Hassan, J. R. Flavell, P. N. Nelson, K. Scott, G. Reynolds, C. M. Constandinou, D. J. Kerr, E. C. Devey, et al.
Effect of Epstein-Barr Virus Infection on Response to Chemotherapy and Survival in Hodgkin's Disease
Blood, July 15, 1999; 94(2): 442 - 447.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
J. Nishikawa, S. Imai, T. Oda, T. Kojima, K. Okita, and K. Takada
Epstein-Barr Virus Promotes Epithelial Cell Growth in the Absence of EBNA2 and LMP1 Expression
J. Virol., February 1, 1999; 73(2): 1286 - 1292.
[Abstract] [Full Text]


Home page
BloodHome page
H. Kanegane, K. Bhatia, M. Gutierrez, H. Kaneda, T. Wada, A. Yachie, H. Seki, T. Arai, S.-i. Kagimoto, M. Okazaki, et al.
A Syndrome of Peripheral Blood T-Cell Infection With Epstein-Barr Virus (EBV) Followed by EBV-Positive T-Cell Lymphoma
Blood, March 15, 1998; 91(6): 2085 - 2091.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. P. Sing, R. F. Ambinder, D. J. Hong, M. Jensen, W. Batten, E. Petersdorf, and P. D. Greenberg
Isolation of Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes That Lyse Reed-Sternberg Cells: Implications for Immune-Mediated Therapy of EBV+ Hodgkin's Disease
Blood, March 15, 1997; 89(6): 1978 - 1986.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. M. Mack, W. Cozen, D. K. Shibata, L. M. Weiss, B. N. Nathwani, A. M. Hernandez, C. R. Taylor, A. S. Hamilton, D. M. Deapen, and E. B. Rappaport
Concordance for Hodgkin's Disease in Identical Twins Suggesting Genetic Susceptibility to the Young-Adult Form of the Disease
N. Engl. J. Med., February 16, 1995; 332(7): 413 - 419.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
O. W. Kamel, M. van de Rijn, L. M. Weiss, G. J. Del Zoppo, P. K. Hench, B. A. Robbins, P. G. Montgomery, R. A. Warnke, and R. F. Dorfman
Reversible Lymphomas Associated with Epstein-Barr Virus Occurring during Methotrexate Therapy for Rheumatoid Arthritis and Dermatomyositis
N. Engl. J. Med., May 6, 1993; 328(18): 1317 - 1321.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society for Investigative Pathology.